规律血液透析患者动静脉瘘动脉瘤的外科治疗特征与结局
该回顾性队列研究分析了11年间规律血液透析合并动静脉瘘动脉瘤并接受手术患者的特征与结局。129例动脉瘤患者中40例需手术,共43次干预,主要表现为覆盖皮肤变薄和溃疡。中位随访53个月,全因死亡率为37.5%,主要死因为脓毒症/肺炎、心肌梗死和心力衰竭。
要点
- 透析患者动静脉瘘动脉瘤形成率较高,部分需外科干预。
- 手术方式以切除联合移植物或静脉间置修复为主。
- 术后全因死亡率37.5%,感染和心血管事件为主要死因。
核心结论
- 规律血液透析患者动静脉瘘动脉瘤形成率较高,合并显著的发病率和死亡率,及时评估和外科干预至关重要。
研究设计与样本
- 回顾性队列研究,纳入11年间规律血液透析并因动静脉瘘动脉瘤接受手术的患者40例(24男16女),平均年龄58±14.6岁,共43次手术干预。
主要发现
- 129例透析患者发生动静脉瘘动脉瘤,其中40例需外科干预。
- 多数动脉瘤表现为覆盖皮肤变薄和溃疡(82.5%)。
- 34例为真性动脉瘤,6例为假性动脉瘤。
- 动脉瘤性动静脉瘘包括26例头臂干瘘、9例桡头干瘘、3例肱动脉移植物、1例尺贵要静脉瘘和1例股-股移植物。
- 术后中位随访53个月(范围1-192),全因死亡率为37.5%,主要死因为脓毒症/肺炎(60%)、心肌梗死和心力衰竭(40%)。
关键数值与推荐
- 手术方式:结扎13例(32.5%)、切除联合移植物间置修复15例(37.5%)、切除联合静脉间置修复11例(27.5%)、端端动静脉瘘1例(2.5%)。
- 从瘘管建立至手术干预的中位时间为52个月(范围4-182)。
临床怎么用
- 对透析患者动静脉瘘动脉瘤应定期评估,出现皮肤变薄或溃疡等高风险特征时及时考虑外科干预。
局限性
- 回顾性单中心设计,样本量有限(40例手术患者),可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To investigate the clinical characteristics, surgical interventions, and outcomes of arteriovenous fistula (AVF) aneurysms, we retrospectively analyzed patients on regular hemodialysis (HD). METHODS: We conducted a cohort study of all patients with HD access who presented with AVF aneurysms and underwent operative procedures over a 11-year period. Patients' demographics, comorbidities, vascular access characteristics, management of aneurysms, complications, and outcomes were analyzed. RESULTS: Of the 700 end-stage renal failure patients, 530 patients were maintained on HD (130 through PermCath and 400 through AV access in terms of AVF and arteriovenous graft). We identified 129 patients who developed AV aneurysms, and 40 of them required surgical interventions (24 men and 16 women) with a mean age of 58 ± 14.6 years. The 40 patients who developed AVF aneurysms underwent 43 surgical interventions. The majority of aneurysms were presented with thinning and ulceration (82.5%) of the overlying skin. Thirty-four patients had true aneurysms and 6 had pseudoaneurysms. The aneurysmal AVF comprised 26 brachiocephalic fistulas, 9 radiocephalic fistulas, 3 brachial artery grafts, 1 ulnar-basilic fistula, and 1 Fem-Fem graft at presentation. Patients were treated mainly with ligation (13; 32.5%), excision and repair with graft interposition (15; 37.5%) or vein interposition (11; 27.5%), and end-to-end AVF (1; 2.5%). The median follow-up postsurgery duration was 53 months (range 1-192) and the median duration from fistula creation to the surgical intervention was 52 months (range 4-182). On follow-up, 34 patients continued on HD, while 5 underwent renal transplantation and 1 shifted to peritoneal dialysis. The overall all-cause mortality rate was 37.5% and the leading causes of mortality were sepsis/pneumonia (60%), myocardial infarction, and heart failure (40%). CONCLUSIONS: In HD patients, the rate of AVF aneurysmal formation is high with a significant rate of morbidity and mortality. Therefore, timely and appropriate evaluation and surgical intervention are crucial.
引用
- Al-Thani H, El-Menyar A, Al-Thani N, et al. Characteristics, Management, and Outcomes of Surgically Treated Arteriovenous Fistula Aneurysm in Patients on Regular Hemodialysis. Ann Vasc Surg. 2017. PMID: 28238919. doi:10.1016/j.avsg.2016.08.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。